Zhang, April <br/><br/>
Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome.  [electronic resource] 

 -  JAMA dermatology  02 2020 
 - 196-200 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>2168-6084 
<br/><br/><label>Standard No.: </label>10.1001/jamadermatol.2019.4141  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Brazil<br/>Child<br/>Child, Preschool<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride--administration & dosage<br/>Female<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Infant<br/>Keratoderma, Palmoplantar--drug therapy<br/>Male<br/>Protein Kinase Inhibitors--administration & dosage<br/>Signal Transduction--drug effects<br/>Sirolimus--administration & dosage<br/>Syndrome<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Treatment Outcome